United Therapeutics Corporation v. Liquidia Technologies, Inc.

Procedural entryThis page is a short order in United Therapeutics Corporation v. Liquidia Technologies, Inc.. Read the opinion of the Court — 74 F.4th 1360
Court of Appeals for the Federal Circuit·Decided November 18, 2022·No. 22-2133·Unpublished

Opinion

Case: 22-2133 Document: 28 Page: 1 Filed: 11/18/2022

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit UNITED THERAPEUTICS CORPORATION, Appellant

v.

LIQUIDIA TECHNOLOGICS, INC., Appellee

2022-2133

Appeal from the U n i t e d S t a t e s Patent and Trademark Office, Patent Trial and Appeal Board in IPR2020-00770. --------------------------------------------------

LIQUIDIA TECHNOLOGICS, INC., Appellant

UNITED THERAPEUTICS CORPORATION, Appellee

2022-2174 Case: 22-2133 Document: 28 Page: 2 Filed: 11/18/2022

2 BRUMFIELD V. IBG LLC

Appeal from the U n i t e d S t a t e s Patent and Trademark Office, Patent Trial and Appeal Board in IPR2020-00770.

ON MOTION

ORDER Upon consideration of the party’s motion to voluntarily dismiss Appeal No. 2022-2174,

IT IS ORDERED THAT: (1) The motion is granted. Appeal No. 2022-2174 is DISMISSED under Fed. R. App. P. 42 (b). (2) Each side shall bear their own costs with respect to Appeal No. 2022-2174. (3) Appeal No. 2022-2174 is deconsolidated from Appeal No. 2022-2133, and the revised caption is reflected above.

November 18, 2022 FOR THE COURT Date

/s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

ISSUED AS A MANDATE (only as to Appeal No. 2022-2174): November 18, 2022

Free access — add to your briefcase to read the full text and ask questions with AI

United Therapeutics Corporation v. Liquidia Technologies, Inc., (Fed. Cir. 2022).

United Therapeutics Corporation v. Liquidia Technologies, Inc. (United Therapeutics Corporation v. Liquidia Technologies, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.